Miracor Medical SA

📍 Hognoul, Belgium🗓 Founded 2008👥 10 employees💰 Last funded Jan 2017
Miracor Medical SA is a European medical device company dedicated to improve clinical outcome of patients with impaired cardiac function. Miracor develops and studies the PiCSO® (Pressure-controlled intermittent Coronary Sinus Occlusion) Impulse System, which is used as an adjunctive technique during the primary PCI procedure for acute myocardial infarction patients. PiCSO therapy seeks to improve coronary microvascular function to reduce infarct size and salvage myocardium, thereby improving outcomes of ST-elevation myocardial infarction (STEMI) patients. Recent Clinical Studies have successfully demonstrated the safety and positive effects of PiCSO on coronary microvascular function and infarct size reduction in STEMi patients. The company is conducting further clinical trials in Europe and plans to initiate a US IDE randomized controlled trial in 2023. Miracor has won several innovation awards and completed financing rounds raising venture capital and public funding. The company was founded in May 2008 by Professor Dr. Dr. Werner Mohl and the European venture capital firms Earlybird and Delta Partners.
2
Total investors
0
Early stage
0
Mid stage
2
Late stage
2008
Founded
Investor geography2 countries
Sweden
1
Austria
1
Frequently asked questions
Who invested in Miracor Medical SA?
Miracor Medical SA has 2 investors on record on gritt.io and 2 late-stage investors.
When did Miracor Medical SA last raise funding?
The most recent investment in Miracor Medical SA recorded on gritt.io was in January 2017.
When was Miracor Medical SA founded?
Miracor Medical SA was founded in 2008.
What industry is Miracor Medical SA in?
Miracor Medical SA operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Miracor Medical SA based?
Miracor Medical SA is headquartered in Hognoul, Belgium.